Cosmetic Dermatology Study

计划入组 75 人 · 首次发布于 2014 年 7 月 25 日

A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects

计划入组 72 人 · 首次发布于 2025 年 8 月 17 日

Outcome of Bronchoscopy in FB Aspiration

计划入组 75 人 · 首次发布于 2025 年 9 月 2 日

Dermatology(Immunocore)

Dermatology (Curexsys)

FB-704

SIPERSTEIN DERMATOLOGY

United States

Rao Dermatology

United States

University Dermatology, Inc.

United States

Kane Biotech Reports First Commercial Sale of revyve™ Wound Gel in Q3 2024

Dermatology Advances: Approvals, Trial Results, and New Guidelines Emerge

GEP Tests Show Promise and Limitations in Melanoma Sentinel Lymph Node Biopsy Decisions